Key Takeaways
- Accenture (ACN) stock rallied approximately 31.5% from October 6 to November 9, closing at $254.37 as shares recovered from their early-October levels.
- Cognizant (CTSH) expects adjusted EPS growth of 8% to 10% in 2026, while Accenture’s normalized EPS is projected to increase approximately 5% in fiscal 2027.
- November 5 TIKR valuation charts show Accenture trading at 17.8x forward earnings versus Cognizant’s 10.6x, representing a valuation premium of approximately 68%.
- Cognizant appears more attractively valued, although modest organic growth and its reliance on acquisitions remain important risks.
What Happened?
Accenture (ACN) stock rallied approximately 31.5% from October 6 to November 9, climbing from $193.40 to $254.37 as investors reassessed the IT consulting company’s earnings outlook.
Accenture reported fiscal fourth-quarter revenue of approximately $18.7 billion, up 6% year over year, while full-year revenue reached approximately $74.2 billion. The stronger results provided a positive backdrop for the stock’s subsequent recovery.
Accenture also delivered fiscal 2026 adjusted EPS of $13.97, an 8% increase, supported by operating improvements and continued demand for consulting and managed services.
CEO Julie Sweet highlighted the company’s performance, stating, “We exceeded our fourth-quarter revenue guidance range,” as Accenture delivered growth across its business.
However, the company’s fiscal 2027 outlook points to a more moderate pace of earnings expansion, raising questions about how much additional growth investors should expect following the rally.
Meanwhile, Cognizant (CTSH) reported third-quarter revenue of approximately $5.7 billion, increasing 4.6% year over year, while improving adjusted operating profitability.
Cognizant also narrowed its 2026 constant-currency revenue growth guidance to 4.0% to 4.4%, compared with its earlier range of 4.0% to 5.5%.
For investors, Accenture’s rebound raises an important question: Does its greater scale and diversified consulting business justify paying substantially more for its earnings than Cognizant?
Accenture’s Earnings Growth Is Expected to Slow in 2027
Accenture’s normalized EPS increased from $12.93 in fiscal 2025 to $13.97 in fiscal 2026, representing approximately 8% earnings growth.
According to TIKR consensus estimates, normalized EPS is projected to reach $14.66 in fiscal 2027, an increase of approximately 5%, before rising another 8% to $15.89 in fiscal 2028.
The projections suggest Accenture’s earnings growth could moderate over the next year before recovering as enterprise technology spending, AI-related consulting demand, and operating efficiencies support profitability.
Accenture’s fiscal 2027 guidance calls for local-currency revenue growth of 3% to 6% and an operating margin of 15.9% to 16.1%, representing 10 to 30 basis points of expansion over fiscal 2026’s adjusted operating margin.
Management also expects diluted EPS of $14.39 to $14.81 in fiscal 2027, representing approximately 3% to 6% growth compared with fiscal 2026 adjusted EPS.
Cognizant offers a different near-term earnings profile.
Management expects adjusted EPS of $5.72 to $5.79 for calendar 2026, representing annual growth of approximately 8% to 10%.
Its adjusted operating margin is expected to reach approximately 16.1%, expanding 30 basis points from 2025 as operating improvements and productivity initiatives support profitability.
However, Cognizant’s revenue outlook reveals an important limitation.
According to its third-quarter earnings supplement, management expects full-year revenue of $22.05 billion to $22.14 billion, with acquisitions contributing approximately 1.5 percentage points to constant-currency growth.
Fourth-quarter revenue growth is projected at 3.2% to 4.7% in constant currency, including approximately 2 percentage points from acquisitions.
This suggests Cognizant’s organic revenue growth remains modest despite improving profitability.
Although Cognizant’s 2026 adjusted EPS growth guidance exceeds Accenture’s projected fiscal 2027 normalized EPS growth, the figures represent different reporting periods and earnings measures, making the comparison directional rather than directly equivalent.
Is Accenture Stock Undervalued or Overvalued?
According to the November 5 TIKR valuation snapshot, Accenture traded at approximately 17.8x forward earnings, compared with its five-year average of 23.7x.
That represents a discount of approximately 25% to its historical average, suggesting Accenture appeared relatively inexpensive compared with its own trading history at the time of the snapshot.
However, Cognizant traded at a substantially lower earnings multiple.
The same TIKR chart package showed Cognizant trading at approximately 10.6x forward earnings, compared with its five-year average of 14.6x, representing a discount of approximately 27%.
Based on those figures, Accenture’s valuation premium over Cognizant stood at approximately 68%, slightly above the approximately 62% premium implied by their respective five-year average multiples.
Investors have historically paid more for Accenture’s greater scale, diversified consulting operations, and established relationships with large enterprise customers.
However, its higher valuation leaves less room for disappointing earnings growth, particularly with fiscal 2027 normalized EPS growth projected to moderate to approximately 5%.
Over the next 12 months, Accenture’s performance will depend on enterprise technology spending, AI-related transformation projects, operating margin expansion, and its ability to convert bookings into revenue.
For Cognizant, the important drivers will be organic revenue growth, successful acquisition integration, productivity improvements, and continued margin expansion.
Cognizant appears more attractively valued on a relative basis, given its lower forward earnings multiple and management’s outlook for continued adjusted EPS growth.
However, that discount also reflects risks surrounding modest organic growth and the sustainability of acquisition-supported revenue expansion.
Accenture likewise appears inexpensive compared with its historical valuation, but its premium over Cognizant makes the projected fiscal 2028 earnings recovery especially important.
For investors comparing the two companies, Cognizant offers the more compelling relative valuation, while Accenture provides greater business scale, diversification, and the potential for a longer-term earnings recovery.
The deciding factor will be whether Cognizant can sustain profitable organic growth without increasingly relying on acquisitions, and whether Accenture can deliver the earnings acceleration reflected in analysts’ longer-term forecasts.
So what is Cognizant stock actually worth?
TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what Cognizant could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!
